In the last trading session, 7.93 million shares of the Bristol-Myers Squibb Co. (NYSE:BMY) were traded, and its beta was 0.42. Most recently the company’s share price was $49.14, and it changed around $0.21 or 0.43% from the last close, which brings the market valuation of the company to $99.59B. BMY currently trades at a discount to its 52-week high of $70.93, offering almost -44.34% off that amount. The share price’s 52-week low was $47.58, which indicates that the current value has risen by an impressive 3.17% since then. We note from Bristol-Myers Squibb Co.’s average daily trading volume that its 3-month average coming to 15.57 million.
Bristol-Myers Squibb Co. stock received a consensus recommendation rating of Hold, based on a mean score of 2.67. If we narrow it down even further, the data shows that 2 out of 22 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 11 recommended BMY as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Bristol-Myers Squibb Co. is expected to report earnings per share of $Harmony Gold Mining Company Lim for the current quarter.
Bristol-Myers Squibb Co. (NYSE:BMY) trade information
Instantly BMY has showed a green trend with a performance of 0.43% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently down -4.23% year-to-date, but still up 1.30% over the last five days. On the other hand, Bristol-Myers Squibb Co. (NYSE:BMY) is -4.75% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $70.55, which translates to bulls needing to increase their stock price by 30.35% from its current value. Analyst projections state that BMY is forecast to be at a low of $55 and a high of $85.
Bristol-Myers Squibb Co. (BMY) estimates and forecasts
Bristol-Myers Squibb Co. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -13.00 percent over the past six months and at a -91.21% annual growth rate that is well below the industry average of 13.30%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 5.14%. Bristol-Myers Squibb Co. earnings are expected to increase by -91.12% in 2024, but the outlook is negative -4.17% per year for the next five years.
BMY Dividends
Bristol-Myers Squibb Co.’s next quarterly earnings report is expected to be released in May. The annual dividend yield of the stock is 4.76 percent and its annual dividend per share was 2.34. It is important to note, however, that the 4.76% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.
